Khan Sitara G, Huda Mohammed S
Department of Cardiology, Guy' s and St Thomas' NHS Foundation Trust, London. United Kingdom.
Department of Diabetes, The Royal London Hospital, Barts Health NHS Trust, London. United Kingdom.
Curr Diabetes Rev. 2017;13(6):590-597. doi: 10.2174/1573399812666161201155941.
With the use of intensive insulin therapy and insulin secretagogues to optimize glycemic control in diabetes, hypoglycemia continues to present a clinical challenge. Hypoglycemia has been implicated in nocturnal sudden death in type 1 diabetes, and the mechanism underlying this is postulated to be cardiac arrhythmia.
This article reviews the evidence surrounding hypoglycemia and cardiac arrhythmia.
A structured search of the Pubmed bibliographic database was undertaken, and relevant peerreviewed articles on the topic were included in the review.
Since the initial description of nocturnal sudden death in type 1 diabetes over twenty years ago, numerous studies have been performed to try and improve our understanding of the effects of hypoglycemia on cardiac rhythm. This includes animal models of diabetes that have permitted valuable insights into the pathophysiology of arrhythmia generation, involving direct effects of hypoglycemia on the cardiac myocyte, effects from sympatho-adrenal activation and a reduced arrhythmia threshold. In humans, the use of tools such as the hypoglycemic clamp or subcutaneous continuous glucose monitoring have helped explore the interaction between hypoglycemia and cardiac rhythm in both controlled and real world settings. Proving a causal link with fatal cardiac arrhythmia is clearly more difficult, as simultaneous monitoring of cardiac rhythm and blood glucose level is rarely performed in this setting. However substantial circumstantial evidence, including that from large randomized clinical trials, exists to support the theoretical risk of arrhythmic death conferred by hypoglycemia. This has reshaped opinion surrounding intensive glucose lowering in patients with diabetes and heart disease, and is reflected in recent international guidelines.
This article reviews the postulated mechanisms, the extensive evidence base and the current recommendations around hypoglycemia and arrhythmia.
在使用强化胰岛素治疗和胰岛素促泌剂优化糖尿病患者血糖控制的过程中,低血糖仍然是一项临床挑战。低血糖与1型糖尿病患者夜间猝死有关,据推测其潜在机制为心律失常。
本文综述了关于低血糖与心律失常的相关证据。
对Pubmed文献数据库进行结构化检索,并将该主题相关的经同行评审的文章纳入本综述。
自二十多年前首次描述1型糖尿病患者夜间猝死以来,已开展了大量研究,试图增进我们对低血糖对心律影响的理解。这包括糖尿病动物模型,其使我们对心律失常发生的病理生理学有了宝贵的认识,涉及低血糖对心肌细胞的直接作用、交感 - 肾上腺激活的影响以及心律失常阈值降低。在人类中,使用低血糖钳夹或皮下连续血糖监测等工具,有助于在受控和实际环境中探索低血糖与心律之间的相互作用。要证明与致命性心律失常存在因果关系显然更为困难,因为在此情况下很少同时监测心律和血糖水平。然而,包括大型随机临床试验证据在内的大量间接证据支持低血糖导致心律失常死亡的理论风险。这重塑了关于糖尿病和心脏病患者强化降糖治疗的观点,并反映在近期的国际指南中。
本文综述了关于低血糖与心律失常的推测机制、广泛的证据基础以及当前的建议。